Round Hill Asset Management’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$6.88M Sell
244,914
-2,350
-1% -$62.6K 4.5% 7
2025
Q4
$6.16M Sell
247,264
-755
-0.3% -$19K 3.88% 8
2025
Q3
$6.32M Buy
248,019
+373
+0.2% +$9.21K 4.16% 6
2025
Q2
$6M Buy
247,646
+64,376
+35% +$1.5M 4.05% 6
2025
Q1
$4.64M Buy
183,270
+31,108
+20% +$814K 3.34% 7
2024
Q4
$4.04M Buy
152,162
+11,514
+8% +$312K 2.85% 10
2024
Q3
$4.07M Sell
140,648
-1,625
-1% -$47.4K 2.69% 9
2024
Q2
$3.98M Sell
142,273
-3,032
-2% -$83.5K 2.54% 10
2024
Q1
$4.03M Sell
145,305
-1,575
-1% -$43.7K 2.44% 11
2023
Q4
$4.23M Sell
146,880
-1,505
-1% -$45.5K 2.66% 10
2023
Q3
$4.92M Sell
148,385
-3,015
-2% -$107K 3.24% 8
2023
Q2
$5.55M Sell
151,400
-2,150
-1% -$83.7K 3.43% 8
2023
Q1
$6.26M Sell
153,550
-4,255
-3% -$184K 3.91% 7
2022
Q4
$8.09M Sell
157,805
-1,225
-0.8% -$58.7K 5% 7
2022
Q3
$6.96M Sell
159,030
-375
-0.2% -$18.2K 4.73% 7
2022
Q2
$8.36M Sell
159,405
-128
-0.1% -$6.52K 5.12% 7
2022
Q1
$8.26M Sell
159,533
-955
-0.6% -$49.6K 4.35% 6
2021
Q4
$9.48M Hold
160,488
4.75% 6
2021
Q3
$6.9M Sell
160,488
-1,450
-0.9% -$64.2K 3.47% 10
2021
Q2
$6.34M Sell
161,938
-450
-0.3% -$17.5K 3.11% 10
2021
Q1
$5.88M Sell
162,388
-292
-0.2% -$10.4K 3.11% 9
2020
Q4
$5.99M Sell
162,680
-9,048
-5% -$332K 3.36% 9
2020
Q3
$5.99M Sell
171,728
-851
-0.5% -$29.8K 3.63% 9
2020
Q2
$5.36M Sell
172,579
-2,387
-1% -$81.1K 3.39% 9
2020
Q1
$5.41M Sell
174,966
-1,655
-0.9% -$56.4K 3.78% 9
2019
Q4
$6.56M Sell
176,621
-962
-0.5% -$34.3K 3.57% 9
2019
Q3
$6.05M Sell
177,583
-316
-0.2% -$11.5K 3.52% 9
2019
Q2
$7.31M Sell
177,899
-8,923
-5% -$354K 4.22% 7
2019
Q1
$7.53M Sell
186,822
-10,144
-5% -$406K 4.52% 7
2018
Q4
$8.16M Sell
196,966
-7,821
-4% -$325K 5.42% 6
2018
Q3
$8.56M Buy
204,787
+1,128
+0.6% +$43.4K 5.06% 6
2018
Q2
$7.14M Sell
203,659
-10,203
-5% -$349K 4.43% 6
2018
Q1
$7.2M Sell
213,862
-8,058
-4% -$277K 4.35% 7
2017
Q4
$7.63M Sell
221,920
-553
-0.2% -$18.9K 4.34% 7
2017
Q3
$7.53M Sell
222,473
-527
-0.2% -$16.9K 4.3% 7
2017
Q2
$7.11M Sell
223,000
-1,924
-0.9% -$60.7K 4.07% 7
2017
Q1
$7.3M Sell
224,924
-105
-0% -$3.31K 4.15% 7
2016
Q4
$6.94M Buy
+225,029
New +$6.87M 4.09% 7

Other funds holding PFE

Round Hill Asset Management's PFE Position: Q1 2026 in Review

Round Hill Asset Management reduced its Pfizer (PFE) stake by 0.95% in Q1 2026, selling an estimated $62.6K and leaving 244,914 shares worth $6.88M. The position accounts for 4.5% of the portfolio, ranked #7.

Round Hill Asset Management first reported a position in PFE in Q4 2016 and has held it in 38 quarters since. The position peaked at $9.48M in Q4 2021. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Round Hill Asset Management held 244,914 shares of Pfizer worth $6.88M as of Q1 2026.
  • Round Hill Asset Management sold 2,350 Pfizer shares in Q1 2026, an estimated $62.6K.
  • Pfizer made up 4.5% of Round Hill Asset Management's portfolio in Q1 2026, its #7 holding.
  • Round Hill Asset Management first reported a position in Pfizer in Q4 2016 and has held it in 38 quarters since.
  • Round Hill Asset Management's Pfizer position peaked at $9.48M in Q4 2021.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Round Hill Asset Management's 13F filing for Q1 2026, filed 14 May 2026.